GET DAILY SIGNALSRocket Lab (RKLB): Analyst Targets Suggest $100 Could Mean +86% Upside Potential
Key Takeaways
- The central target of $100 is the arithmetic mean of nine recent, verified analyst price targets (about $103 before rounding), not a guarantee of future performance.
- With Rocket Lab Corporation (RKLB) last trading near $53.67, reaching $100 implies roughly 86% upside — a very large move by almost any standard.
- The verified target range is unusually wide, from $67 (Goldman Sachs) to $132 (Stifel), reflecting real disagreement about the Neutron rocket timeline.
- Supporting the bull case are a record $2.36 billion backlog, roughly 52% trailing revenue growth, and substantial U.S. Space Force and commercial contracts.
- The biggest risks are the Neutron first launch slipping into 2027, persistent net losses, and a price-to-sales ratio that leaves little margin for error.
Understanding the Current Analyst Consensus
Rocket Lab has solid sell-side coverage, though the October 2026 selloff tied to the Neutron delay prompted several estimate resets. The $100 central target reflects the average of nine recent attributed forecasts reviewed after that news: Cantor Fitzgerald at $122, Stifel at $132, Needham at $120, Roth Capital at $110, Clear Street at $105, KeyBanc at $100, Citizens at $90, Raymond James at $80, and Goldman Sachs at $67. The simple average comes to roughly $103 before rounding down to $100, spanning a broad $67-to-$132 band.
Broader aggregator data from about 19 to 21 analysts shows an average target still in the low $100s, with a consensus leaning mostly Buy or Strong Buy and just a few Holds and no Sells. The spread highlights differing views on how much the Neutron timeline shift truly matters long term.
Where the Stock Stands Today and What $100 Would Require
Rocket Lab Corporation (RKLB) focuses on Electron rocket launches, spacecraft systems, and on-orbit services. Shares closed near $53.67 on October 21, 2026, down about 65% from the 52-week high of $151.00 and sitting below both the 50-day and 200-day moving averages. Hitting $100 would mean an 86% advance, a substantial re-rating for a business that has yet to turn consistently profitable.
Trailing twelve-month revenue reached roughly $769 million, up more than 50% year over year, while the backlog hit a record $2.36 billion. Net losses remain around $165 million over the past year, and the stock trades near 53 times sales—an ambitious multiple for a pre-profit launch operator. Much of the upside case rests on Neutron, the planned reusable medium-lift vehicle with far greater capacity than Electron.
Factors That Could Help Push Shares Higher
The core growth narrative continues to hold. Launch demand stays robust, and the company’s Electron flight cadence, multiple sites, and mix of commercial and government customers provide a solid base. Major contracts include roughly $663 million in U.S. Space Force awards and a 20-launch deal with Synspective. Third-quarter revenue guidance sits at $250–$265 million, and the backlog has more than doubled year over year. A successful Neutron debut could prompt upward re-ratings from analysts who view the medium-lift segment as expanding. I also checked comparable names using Tickeron’s AI Screener to see how Rocket Lab stacks up on growth metrics.
Key Risks That Could Keep the Target Out of Reach
Execution remains the primary hurdle. Neutron’s first launch slipped from late 2026 into 2027 after engineers discovered voids in the carbon-composite tank dome, requiring a rebuild. Several firms lowered targets post-delay while keeping Buy ratings. The company continues to burn cash, and positive free cash flow is not expected until well after Neutron’s initial success. An $8 billion Iridium Communications acquisition adds further integration and financing questions. Any prolonged delay or test setback could pressure the current valuation further.
Technical Picture and Levels to Watch
The recent decline marks one of the sharpest drawdowns in the stock’s history. The 52-week range runs from $37.57 to $151.00, with the prior high serving as distant resistance. Support near $50 and the 52-week low around $37.57 mark important lower levels. Trading below both moving averages keeps the intermediate trend negative, so any sustained move toward $100 would first need to reclaim the mid-$60s and then the $80s. A five-year beta near 2.9 highlights the elevated volatility relative to the broader market.
Timeline and Items Worth Monitoring
Most analyst targets cover a roughly 12-month horizon, though updates occur frequently. The next earnings release, expected in early November, will show whether third-quarter results align with guidance and whether the backlog keeps expanding. Key items to track include Neutron manufacturing progress, any revised launch timing, updates on the Iridium deal, additional contract wins, and further target revisions. Broader interest-rate moves and risk sentiment will also influence this high-beta name.
AI Daily Buy/Sell Signals
I occasionally reference Tickeron’s AI Daily Buy/Sell Signals when reviewing volatile names like this one. The tool applies artificial intelligence to scan thousands of stocks and ETFs, producing Buy, Sell, or Hold signals based on technical and market-condition shifts. For a stock with wide price swings, it offers an efficient way to flag potential changes alongside traditional analysis.
Exploring Tickeron’s AI Tools for Portfolio Monitoring
In my own research process I find Tickeron’s AI Daily Buy/Sell Signals helpful for tracking momentum shifts in growth-oriented names. The platform continuously analyzes market data and technical patterns, which can complement fundamental work when following companies with complex execution timelines. It is one of several resources I use to stay organized without replacing independent judgment.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
RKLB's RSI Oscillator ascending out of oversold territory
The RSI Oscillator for RKLB moved out of oversold territory on November 06, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 32 similar instances when the indicator left oversold territory. In 30 of the 32 cases the stock moved higher. This puts the odds of a move higher at 90%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on November 06, 2026. You may want to consider a long position or call options on RKLB as a result. In 81 of 86 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 90%.
The Moving Average Convergence Divergence (MACD) for RKLB just turned positive on November 09, 2026. Looking at past instances where RKLB's MACD turned positive, the stock continued to rise in 40 of 43 cases over the following month. The odds of a continued upward trend are 90%.
RKLB moved above its 50-day moving average on November 10, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +18.16% 3-day Advance, the price is estimated to grow further. Considering data from situations where RKLB advanced for three days, in 265 of 303 cases, the price rose further within the following month. The odds of a continued upward trend are 87%.
RKLB may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.
The 10-day moving average for RKLB crossed bearishly below the 50-day moving average on October 13, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 7 of 9 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 78%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where RKLB declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 84%.
The Aroon Indicator for RKLB entered a downward trend on November 10, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 5 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (9.717) is normal, around the industry mean (5.050). RKLB's P/E Ratio (-196.556) is considerably lower than the industry average of (17.247). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.110). Dividend Yield (0.000) settles around the average of (0.055) among similar stocks. P/S Ratio (48.309) is also within normal values, averaging (18.367).
The Tickeron PE Growth Rating for this company is 22 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 64 (best 1 - 100 worst), indicating fairly steady price growth. RKLB’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 68 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. RKLB’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 78, placing this stock better than average.
The Tickeron SMR rating for this company is 93 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
Industry AerospaceDefense
Advertisement